Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Article Details

Authors
Martina Burlando, Riccardo Castelli, Emanuele Cozzani, Aurora Parodi

Article Type
Erratum

DOI
10.7573/dic.2021-6-8

Temozolomide and oral etoposide in children with recurrent malignant brain tumors
Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

Article Page

Abstract

The authors wish to make the following corrections to their article:

Burlando M, Castelli R, Cozzani E, Parodi A. Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting. Drugs in Context 2021; 10: 2021-2-6. DOI: 10.7573/dic.2021-2-6

Download free full text PDF

An open access, peer-reviewed journal focussing on the latest evidence and innovations in drug treatment across all therapeutic areas

Sign up for Article Alerts

Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Article Details

Related Articles

Article Page

An open access, peer-reviewed journal focussing on the latest evidence and innovations in drug treatment across all therapeutic areas

Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Article Details

Related Articles

Article Page

Loading..

Loading, Please Wait!